Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

WEIBEL SCIENTIFIC A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   0.3% 2.5% 2.6% 2.5% 0.4% 0.4% 3.9% 3.8%   Credit score (0-100)   100 64 61 61 99 100 50 51   Credit rating   AAA BBB BBB BBB AAA AAA BBB BBB   Credit limit (mDKK)   39.6 0.0 0.0 0.0 46.5 65.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 324 367 419 522 576 576 576   Gross profit   157 194 238 270 300 450 0.0 0.0   EBITDA   63.6 194 238 270 42.0 150 0.0 0.0   EBIT   54.3 194 238 270 29.8 136 0.0 0.0   Pre-tax profit (PTP)   54.6 40.8 57.1 52.8 17.7 130.2 0.0 0.0   Net earnings   40.4 40.8 57.1 52.8 15.9 106.1 0.0 0.0   Pre-tax profit without non-rec. items   54.6 194 238 270 17.7 130 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   136 0.0 0.0 0.0 169 162 0.0 0.0   Shareholders equity total   319 330 366 391 388 494 419 419   Interest-bearing liabilities   16.8 0.0 0.0 0.0 273 179 0.0 0.0   Balance sheet total (assets)   414 503 586 785 852 1,080 419 419   Net Debt   -22.5 0.0 0.0 0.0 264 163 -408 -408     See the entire balance sheet 1.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 324 367 419 522 576 576 576   Net sales growth   0.0% 0.0% 13.3% 14.2% 24.4% 10.5% 0.0% 0.0%   Gross profit   157 194 238 270 300 450 0.0 0.0   Gross profit growth   29.7% 23.2% 23.1% 13.4% 11.1% 49.8% -100.0% 0.0%   Employees   123 163 213 263 332 373 0 0   Employee growth %   0.0% 32.5% 30.7% 23.5% 26.2% 12.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   414 503 586 785 852 1,080 419 419   Balance sheet change%   9.6% 21.6% 16.5% 33.9% 8.5% 26.8% -61.2% 0.0%   Added value   63.6 193.6 238.3 270.1 29.8 149.6 0.0 0.0   Added value %   0.0% 59.7% 64.9% 64.4% 5.7% 26.0% 0.0% 0.0%   Investments   -45 -139 0 0 207 44 -265 0   Net sales trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 59.7% 64.9% 64.4% 8.1% 26.0% 0.0% 0.0%   EBIT %   0.0% 59.7% 64.9% 64.4% 5.7% 23.6% 0.0% 0.0%   EBIT to gross profit (%)   34.5% 100.0% 100.0% 100.0% 9.9% 30.3% 0.0% 0.0%   Net Earnings %   0.0% 12.6% 15.5% 12.6% 3.0% 18.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 12.6% 15.5% 12.6% 5.4% 20.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 59.7% 64.9% 64.4% 3.4% 22.6% 0.0% 0.0%   ROA %   14.4% 42.2% 43.8% 39.4% 4.6% 15.8% 0.0% 0.0%   ROI %   16.6% 44.7% 43.8% 39.4% 5.2% 21.7% 0.0% 0.0%   ROE %   13.5% 12.6% 16.4% 14.0% 4.1% 24.0% 0.0% 0.0%   1.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   77.8% 100.0% 100.0% 100.0% 40.2% 42.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 85.3% 92.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 83.6% 89.1% -70.8% -70.8%   Net int. bear. debt to EBITDA, %   -35.4% 0.0% 0.0% 0.0% 628.4% 108.9% 0.0% 0.0%   Gearing %   5.3% 0.0% 0.0% 0.0% 70.4% 36.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.4% 0.0% 0.0% 0.0% 14.9% 10.0% 0.0% 0.0%   1.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   3.4 0.0 0.0 0.0 1.5 1.2 0.0 0.0   Current Ratio   4.7 0.0 0.0 0.0 1.9 1.9 0.0 0.0   Cash and cash equivalent   39.3 0.0 0.0 0.0 9.0 16.5 0.0 0.0   1.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 71.6 36.1 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 53.4 94.5 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 121.2% 139.4% 70.8% 70.8%   Net working capital   216.2 0.0 0.0 0.0 300.7 370.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 57.6% 64.3% 0.0% 0.0%   1.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 2 2 2 2 2 0 0   Added value / employee   1 1 1 1 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 1 1 1 0 0 0 0   EBIT / employee   0 1 1 1 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0